Rheumatoid arthritis (RA) is a systemic inflammatory disorder, with the most common extra-
articular manifestation of RA being lung involvement. While essentially any of the lung …

Interstitial lung disease (ILD) is an increasingly recognized complication of rheumatoid
arthritis (RA) and is associated with significant morbidity and mortality. In addition …

Background Given the phenotypic similarities between rheumatoid arthritis (RA)–associated
interstitial lung disease (ILD)(hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we …

Question addressed by the study Methotrexate (MTX) is a key anchor drug for rheumatoid
arthritis (RA) management. Fibrotic interstitial lung disease (ILD) is a common complication …

Objectives To compare mortality risks in patients with rheumatoid arthritis-associated
interstitial lung disease (RA-ILD) and patients with RA without ILD. Design Matched cohort …

Objectives. The prevalence of interstitial lung disease (ILD) in RA is∼ 5%. Previous work
identified increasing age, active articular disease and articular damage as risk factors for RA …

Interstitial lung disease (ILD) is a common pulmonary manifestation of rheumatoid arthritis.
There is lack of clarity around predictors of mortality and disease behaviour over time in …

Rheumatoid arthritis (RA) is a debilitating autoimmune disease with grave physical,
emotional and socioeconomic consequences. Despite advances in targeted biologic and …

No published epidemiological study has specifically focused on the prevalence of
established rheumatoid arthritis (RA), as epidemiologists do not study established RA …

Background Clinical quality registries (CQRs) are playing an increasingly important role in
improving health outcomes and reducing health care costs. CQRs are established with the …